BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
Metabolism of xenobiotics
,
Breast Cancer
,
Leukocyte
,
Amniocentesis
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
K ras oncogenes
Summary
General Info
Curated Studies
Most Correlated Studies
Duodenum tissue from high-fat diet fed mice expressing activated K-ras
Skin tissue from IQGAP1 knockout mice after acute oncogenic RAS activation
Lung tumor gene expression in a mutant K-ras mouse model with and without deletion of Tgfbr2
MEF gene expression induced by oncogenic Kras and Wt1
Acute myelogenous leukemia expression profile changes following removal of oncogenic NRAS expression
Explore Curated Studies Results
Literature
Most Relevant Literature
A fluorescence-electrochemiluminescence dual-mode sensor based on a "switch" system for highly selec…
Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical signi…
Association between C-myc and K-ras gene polymorphisms and non-Hodgkin lymphoma.
Interaction between RAS gene and lipid metabolism in cancer.
Mechanism-Based Redesign of GAP to Activate Oncogenic Ras.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/…
Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC
K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposur…
Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung …
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ